Active Ingredient History

NOW
  • Now
Zonisamide is an antiseizure drug chemically classified as a sulfonamide and unrelated to other antiseizure agents. The precise mechanism by which zonisamide exerts its antiseizure effect is unknown, although it is believed that the drug blocks sodium and calcium channels, which leads to the suppression of neuronal hypersynchronization (i.e. convulsions). Sonisamide has also been found to potentiate dopaminergic and serotonergic neurotransmission but does not appear to potentiate syanptic activity by GABA (gamma amino butyric acid). Zonisamide binds to sodium channels and voltage sensitive calcium channels, which suppresses neuronal depolarization and hypersynchronization. Zonisamide also inhibits carbonic anhydrase to a weaker extent, but such an effect is not thought to contribute substantially to the drug's anticonvulsant activity. Zonisamide is approved in the United States, United Kingdom, and Australia for adjunctive treatment of partial seizures in adults and in Japan for both adjunctive and monotherapy for partial seizures (simple, complex, secondarily generalized), generalized (tonic, tonic-clonic (grand mal), and atypical absence) and combined seizures.   NCATS

  • SMILES: NS(=O)(=O)CC1=NOC2=C1C=CC=C2
  • InChIKey: UBQNRHZMVUUOMG-UHFFFAOYSA-N
  • Mol. Mass: 212.226
  • ALogP: 1.85
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$0.0892 - $15.8456

Australia

$0.1573 - $0.4371
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

1,2-benzisoxazole-3-methanesulfonamide | 3-(sulfamoylmethyl)-1,2-benzisoxazole | 3-sulfamoylmethyl-1,2-benzisoxazole | ad 810 | ad-810 | benzo[d]isoxazol-3-yl-methanesulfonamide | ci 912 | ci-912 | elan brand of zonisamide | exceglan | excegram | excegran | pd-110843 | zonegran | zonisamida | zonisamide | zonisamide monosodium | zonisamidum

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue